 |
answer text |
<p>The number of people registered with diabetes at a general practitioner (GP) practice
in 2017-18 by clinical commissioning group and diabetes type in England can be found
in the attached table.</p><p>The Department is doing everything appropriate to prepare
for leaving the European Union. We want to reassure patients that our plans should
help to ensure the uninterrupted supply of medicines and medical products, including
insulin, once we have left the EU.</p><p>As part of our EU exit preparations, we are
implementing a multi-layered approach to mitigate potential disruption to supply,
which consists of stockpiling where possible, securing freight capacity, changing
or clarifying regulatory requirements, procuring additional warehousing, working closely
with industry to improve trader readiness and putting in place the National Supply
Disruption Response to manage potential shortages.</p><p>All three suppliers of insulin
have publicly stated that they have significantly increased their United Kingdom stockpiles,
and have met the Government request that they hold at least six weeks’ worth of extra
stock in addition to their usual operational stocks.</p>
|
|
